← Back to all trials
Completed
NCT07719413
A Clinical Trial to Compare the Photoprotective Effects of Cucumber Seed Extract vs Placebo in Filipino Adults by Measurement of Minimal Erythema Dose
Conditions: Healthy Human Volunteers With Fitzpatrick Skin Type III-V, Sunburn, Erythema
Sex: All
Ages: 18 Years – 59 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 29
Sponsor: DOH - Tondo Medical Center
Location: DOH-Tondo Medical Center Department of Dermatology and Venereology Manila National Capital Region
Summary
A monocentric, randomized, split-body, double-blind, controlled trial was conducted on 29 Filipino adults with Fitzpatrick skin types III-V. Topical 2% and 4% cucumber seed extract gels and placebo were applied to randomized sites on the lower back, followed by incremental narrow-band UVB exposure. MED was assessed 24 hours post-exposure. Repeated measures ANOVA and paired t-tests were used for statistical analysis.
Eligibility Criteria
Inclusion Criteria:
\- Filipinos aged 18 to 59 years with Fitzpatrick skin phototypes III to V were included in the study.
Exclusion Criteria:
* Elderly and pediatric populations were excluded due to differences in skin structure, immune responses, and the presence of age-related comorbidities that may confound study findings.
* Additional exclusions applied to individuals who were pregnant or breastfeeding;
* Had a history of phototoxic, photoallergic, or abnormal responses to sunlight; ----Reported allergies to cosmetic products, sunscreens, topical drugs, cucumber, or any study formulation component
* Participants were also excluded if they presented with pre-existing or dormant dermatologic conditions, sunburn, suntan, scars, active lesions, or uneven pigmentation on the lower back.
* Other exclusion criteria included current or recent use of medications known to cause hyperpigmentation (e.g., minocycline, clofazimine, amiodarone, antimalarials, chemotherapeutic agents), systemic treatments affecting skin status within the past 15-30 days, sun exposure of the lower back within four weeks prior to inclusion, or intake of skin-whitening supplements such as glutathione within one month before the study.
Source: ClinicalTrials.gov (NCT07719413). StuddyBuddy aggregates publicly available trial information.